CXCL8 and neoplasm: By attenuating IL-1β, IL-6, IL-8 and related chemokines, statins may weaken the inflammatory pathways that sustain tumour growth and immune evasion in cancer and strengthen the efficacy of therapeutic regimens in cancer patients.